Navigation Links
Advance Nanotech's Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition
Date:5/22/2008

NEW YORK, May 22 /PRNewswire-FirstCall/ -- Advance Nanotech, Inc., (OTC Bulletin Board: AVNA), announced today that its Owlstone Nanotech Inc. subsidiary has been selected as one of four finalists for the 2008 Royal Academy of Engineering MacRobert Award, the UK's premier award for innovation in engineering. HRH the Duke of Edinburgh will present a 50,000 pounds Sterling prize and the gold award medal to the winner of this year's competition at the Academy Awards Dinner in London on June 9th, 2008. The MacRobert award recognizes the successful development of innovative ideas in engineering. The academy seeks to demonstrate the importance of engineering and the role of engineers and scientists in contribution to national prosperity and internal prestige.

"Our technology enables unprecedented miniaturization of sensors with superior analytical capability, the ability to be programmed and reprogrammed to detect a wide range of substances, and high selectivity and sensitivity," commented Andrew Koehl, founder of Owlstone and original inventor of its core technology. "Our commercial opportunity is enormous given the need for new and innovative deployment scenarios in chemical detection for homeland security, industrial process control, environmental and healthcare markets. We are deeply honored to be chosen as a finalist candidate for the prestigious MacRobert Award and are proud to be recognized among the three highly regarded companies that have also achieved 2008 finalist status, The Automation Partnership, Johnson Matthey, and Touch Bionics."

Owlstone has successfully developed a silicon chip that can detect chemicals in the ambient air. What once required a large enclosure and connected apparatus due to the sheer size of conventional sensors has been reduced down to a dime sized silicon chip that can detect a wide variety of chemicals in real time from virtually any location. The system can then be connected to a wireless communication system to
'/>"/>

SOURCE Advance Nanotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
2. Advanced Analytical Unveils New Instrument for Rapid Microbial Identification at BIO 2008
3. Advance Nanotech Reports First Quarter 2008 Financial Results
4. Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R)
5. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
6. Advanced Life Sciences Announces First Quarter 2008 Financial Results
7. Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea
8. Advanced Life Sciences to Host 2008 First Quarter Financial Results Conference Call and Webcast
9. Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing
10. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
11. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
... March 10 AutoGenomics, a leader in,developing au...ay that it,will be among the leading healthcare an...nnual Cowen Health Care Conference that will be he...Massachusetts. Fareed Kureshy,President and Chief ...company, its automated molecular testing platform ...
...sed on data previously reported, communicated in l...DGEWATER, N.J., March 7 Ortho Biotech Products, L...CRIT(R) (Epoetin alfa),following guidance from the... labeling for all drugs within the erythropoiesis-...the label were based on an unplanned interim analy...
...E, Ind. - The National Nuclear Security Administra...nt for a research center at Purdue University,s Di...ommercial and defense applications, Purdue officia...focus on the behavior and reliability of miniature...ence chosen by the NNSA. , About 35 researchers a...
Other Biology Technology:Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 2Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 3Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 5Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 6Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 7Purdue leads center to simulate behavior of micro-electromechanical systems 2Purdue leads center to simulate behavior of micro-electromechanical systems 3Purdue leads center to simulate behavior of micro-electromechanical systems 4
(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
Breaking Biology News(10 mins):Stem cells battle for space 2Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 1Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 3Nexicon Technology to Protect Healthcare Industry 52924 1Nexicon Technology to Protect Healthcare Industry 52924 2Nexicon Technology to Protect Healthcare Industry 52924 3Nexicon Technology to Protect Healthcare Industry 52924 4Nexicon Technology to Protect Healthcare Industry 52924 5Must Haves for Your Summer Vacation Bag 52922 1Must Haves for Your Summer Vacation Bag 52922 2Must Haves for Your Summer Vacation Bag 52922 3
...(April 13, 2008, 1:00 p.m. ET) Research published ...ific inhibitors of a cell death pathway, termed ne...rotein that can direct cells into necrosis. Induce... form of necrotic death can result in tissue damag...he findings present a novel avenue for drug develo...
... to significantly boost our understanding of the f...Anglia (UEA) and the Lowestoft-based Centre for En... are launching a new strategic alliance. , The al...een the two institutions and establish exciting ne... climate change on the marine environment will inf...
... being presented today (11 April) at the UK Nation...nburgh could offer hope that bone stem cells may b...s one of the main symptoms of osteoarthritis. , S...identified stem cells within articular cartilage o... in the body like full stem cells, has the ability...
Other Biology News:Stopping unwanted cell death: Implications for drug discovery 2Stopping unwanted cell death: Implications for drug discovery 3New UEA-Cefas alliance launched 2Stem cells offer cartilage repair hope for arthritis sufferers 2
PCASMC (P350-05) from European Collection of Cell Cultures (ECACC)
Rabbit Anti-alpha-N-Catenin Polyclonal Antibody, Unconjugated from Cell Signaling Technology
BioDoc-It System from UVP
AC1 Auto System, OptiChemi™ Camera from UVP
Biology Products: